Skip to main content

Sarcoidosis clinical trials at UCSF
1 in progress, 0 open to new patients

  • Use of CXCL9 as a Biomarker of Acthar Efficacy

    Sorry, not yet accepting patients

    The objective is this study is to test whether use of Acthar gel in the context of sarcoidosis will lead to improved symptoms and lung function and correlate with decreased levels of predictive blood biomarkers, like chemokine ligand 9 (CXCL9).

    San Francisco, California